OUP (Osage University Partners) — 2018 Investments

3 investments dated 2018 · listed companies and verified rows first · show all

Beam Therapeuticsbeamtx.com in 𝕏NASDAQ: BEAMNov 2018

Beam Therapeutics develops gene-editing medicines, particularly base editors and precision genome editing technologies, to create lifelong cures for patients with serious genetic diseases.

BiotechDeep TechMedical DevicesCambridge, US

David R. Liu(Founder)inJ. Keith Joung(Founder)inFeng Zhang(Founder)David R. Liu, Ph.D.(Founder and Inventor)J. Keith Joung, M.D., Ph.D.(Founder and Inventor)Feng Zhang, Ph.D.(Founder and Inventor)

Co-investorsARCH Venture Partners Dreamers VC Eight Roads Ventures F-Prime Capital Foresite Capital GV (Google Ventures)+2 more

CounterflowAIcounterflow.aiJan 2018

Crozet, US

Randy Caldejon(Chairman, Chief Executive Officer and President)Erik Breuhaus(Chief Financial Officer)Peter Shaw(Vice President)in

BoardMatthew Swartz(Director)

Co-investorsTFX Capital Tiburon

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Perceptive Automata

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.